Back to mobile site

INmune Bio, Inc. (INMB) Tops Q2 EPS by 4c

August 7, 2023 4:42 PM EDT

INmune Bio, Inc. (NASDAQ: INMB) reported Q2 EPS of ($0.36), $0.04 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings